Buy Wholesale and maintain an Active status for 2 months and we will refund your $39 Distributor Fee![]()
07-SEPTEMBER-2008 03:17:44 - Prodrug January 2008 A prodrug is a pharmacological substance drug that is administered in an inactive or significantly less active form. Once administered, the prodrug is metabolised in vivo into an active metabolite. The rationale behind the use of a prodrug is generally for absorption, distribution, metabolism, and excretion ADME optimization. Prodrugs are usually designed to improve oral bioavailability, with poor absorption from the gastrointestinal tract usually being the limiting factor, often due to the chemical properties of the drug. Additionally, the use of a prodrug strategy increases the selectivity of the drug for its intended target. An example of this can be seen in many chemotherapy treatments, in which the reduction of adverse effects is always of paramount importance. Drugs used to target hypoxic cancer cells, through the use of redox-activation, utilise the large quantities of reductase enzyme present in the hypoxic cell to convert the drug into its cytotoxic form, essentially activating it. As the prodrug has low cytotoxicity prior to this activation, there is a markedly lower chance of it attacking healthy, non-cancerous cells which reduces the side-effects associated with these chemotherapeutic agents. In rational drug design, the knowledge of chemical properties likely to improve absorption and the major metabolic pathways in the body allows the modification of the structure of new chemical entities for improved bioavailability. Sometimes the use of a prodrug is unintentional, however, especially in the case of serendipitous drug discoveries, and the drug is only identified as a prodrug after extensive drug metabolism studies. Some prodrugs, such as Codeine and Psilocybin, also occur naturally. Contents 1 Classification 2 Examples 3 See also 4 External links Classification Prodrugs can be classified into two types based on their sites of conversion into the final active drug form: Type I, those that are converted intracellularly e.g., anti-viral nucleoside analogs, lipid-lowering statins, antibody-directed/gene-directed enzyme prodrugs ADEP/GDEP for chemotherapy, and Type II, those that are converted extracellularly, especially in digestive fluids or the systemic circulation e.g., etoposide phosphate, valganciclovir, fosamprenavir. Both types can be further categorized into subtype A or B, based on additional criteria. Those for the Type IA and IB are whether or not the cellular converting location is the site of therapeutic action. For the Type IIA and IIB, they are categorized depending on whether the conversion occurs in the gastrointestinal GI fluids or systemic circulation see Table 1; Wu and Farrelly, Toxicology 236:1-6, 2007. Table 1: Classification of prodrugs Type Converting site Subtype Tissue location of conversion Examples Type I Intracellular Type IA Therapeutic target tissues/cells Zidovudine, 5-Flurouracil Type I Intracellular Type IB Metabolic tissues liver/lung etc Captopril, Cyclophosphamide Type II Extracellular Type IIA GI fluid Sulfasalazine, Loperamide oxide Type II Extracellular Type IIB Systemic circulation Fosphenytoin, Bambuterol A prodrug can belong to both a Type IA and IB category when the site of the therapeutic target and conversion are the same e.g., HMG Co-A reductase inhibitors. Examples Enalapril is converted by esterase to the active enalaprilat Valacyclovir is converted by esterase to the active acyclovir Fosamprenavir is hydrolysed to the active amprenavir Levodopa is converted by DOPA decarboxylase to the active dopamine Chloramphenicol succinate ester is used as intravenous prodrug of chloramphenicol, because pure chloramphenicol does not dissolve in water Psilocybin is dephosphorylated to the active psilocin Heroin is deacetylated by esterase to the active morphine Codeine is demethylated by the liver enzyme CYP2D6 to the active morphine, as well as several other compounds that may be active in analgesia Molsidomine is metabolized into SIN-1 which decomposes into the active compound nitric oxide Paliperidone Invega is an atypical antipsychotic for schizophrenia. It's the active metabolite of risperidone Risperdal. See also Toxification External links Special Issue on Prodrugs: from Design to Applications Retrieved from http://en..org/wiki/Prodrug Categories: Pharmacology | ProdrugsHidden category: Articles needing additional references from January 2008 Views Article Discussion this page History Personal tools Log in / create account Navigation Main page Contents Featured content Current events Random article Search Go Search Interaction Community portal Recent changes Contact Donate to Help Toolbox What links here Related changes Upload file Special pages Printable version Permanent link Cite this page Languages Català Deutsch Italiano 日本語 Polski РуÑ?Ñ?кий SlovenÅ¡Ä?ina Suomi Svenska ไทย 䏿–‡ This page was last modified on 2 August 2008, at 17:41
39 Reasons to Drink Acai Juice Every Day
What is MonaVie - Watch the 8-minute video
Discovering MonaVie Video
The Power of You Video
Effects of MonaVie Active on Antioxidant Capacity in Humans
Log into your Wholesale MonaVie Account
So many of us do not eat a balanced diet, get enough sleep, have too much stress, or are impacted with toxins and pollutants. Drinking 2 ounces of MonaVie twice a day will help your body detoxify as well as build your immune system. Its the smartest thing you can do for yourself, so start today. Buying MonaVie through our company guarantees you support 7 days a week and, if you would like to share MonaVie with your family and friends we will guide you from start to finish.
1. Click on Enroll Now (30 - 55% off retail price)
2. Pay $39 for your Wholesale ID number.
3. NO minimum order required.
4. MonaVie is delivered to your door in 3 to 5 days.